Interested in learning more? Schedule a consultation with a network expert today to explore our comprehensive suite of network offerings, ensuring your organization's needs are met with precision.
Interested in learning more? Schedule a consultation with a network expert today to explore our comprehensive suite of network offerings, ensuring your organization's needs are met with precision.
Mitchell today announced plans to expand its collaboration with Tractable through a proposed, exclusive agreement focused on optimizing the vehicle intake process. By connecting Tractable’s LumaScanner vehicle inspection system with Mitchell’s automated estimating solution, Mitchell Intelligent Estimating, the companies intend to help North American multi-site operators (MSOs) and independent collision repair centers accelerate damage assessment and preliminary estimate creation.
Pharmaceutical products classified as "opportunistic" exploit pricing gaps and regulatory variability to drive disproportionate costs with little-to-no added clinical value. While opportunistic products represent a small fraction of overall prescription volume, their financial impact is significant. This trends analysis identifies where clinical and cost interventions can have the greatest impact.
This section of our drug trends analysis takes a closer look at the current state of opioid utilization and spend across in-network and out-of-network channels. While the overall trajectory is favorable, the data also reveals areas of concern that warrant continued vigilance and targeted intervention.
Mitchell today announced the release of Mitchell Intelligent Estimating for U.S. and Canadian MSOs and independent collision centers. Already relied upon by North America’s leading auto insurers, the solution uses vehicle-damage photos to automatically generate a preliminary estimate in minutes, helping to streamline the appraisal process and improve estimator productivity and consistency.
Explore the rise in nuclear verdicts and social inflation, with insights from Enlyte's Michele Hibbert on litigation trends driving higher claims costs.
Explore Enlyte’s latest drug trends data in Business Insurance, highlighting declining opioid prescriptions, alternative pain treatments and strategies to manage workers’ comp pharmacy costs.